Roche buys rights to new drug

Note: This section contains information in English only.
Source: Dukascopy Bank SA
The Swiss drug maker Roche has made a deal with Pfizer and Roivant to purchase the right to a new bowel diseases drug for a total of $71. Billion.

Actual Topics